Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

11.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

5.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.2K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

74
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AOP Network Box: An Integrative Framework for Bridging Adverse Outcome Pathways and Biological Networks.

Chemical research in toxicology·2026
Same author

scMix: learning temporal dynamics of gene expression under irregular time intervals.

Bioinformatics (Oxford, England)·2026
Same author

BIDpred: unraveling B cell Immunodominance hierarchical pattern using statistical feature discovery and deep learning prediction.

Frontiers in immunology·2025
Same author

Critical assessment of missense variant effect predictors on disease-relevant variant data.

Human genetics·2025
Same author

Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.

Human genetics·2025
Same author

B cell epitope prediction by capturing spatial clustering property of the epitopes using graph attention network.

Scientific reports·2024

Related Experiment Video

Updated: Mar 21, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Using reverse docking for target identification and its applications for drug discovery.

Aeri Lee1, Kyoungyeul Lee1, Dongsup Kim1

  • 1a Department of Bio and Brain Engineering , KAIST , Daejeon , South Korea.

Expert Opinion on Drug Discovery
|May 18, 2016
PubMed
Summary

Reverse docking identifies potential drug targets by screening ligands against receptor databases. Further development is needed to address computational efficiency and scoring normalization for broader drug discovery applications.

Keywords:
Reverse dockingbinding pocketdrug discoverytarget databasetarget identification

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Traditional molecular docking identifies ligands for a target, while reverse docking identifies targets for a ligand.
  • Reverse docking aids in discovering new drug targets, understanding drug mechanisms, and predicting adverse effects.

Purpose of the Study:

  • To review the evolution and applications of reverse docking methods in drug discovery over the past 15 years.
  • To discuss key components of reverse docking, including target databases, tools, and servers.

Main Methods:

  • Literature review of reverse docking methodologies.
  • Analysis of reverse docking applications in target identification and drug discovery.

Main Results:

  • Reverse docking has evolved significantly, offering diverse applications in identifying drug targets and understanding molecular mechanisms.
  • The review covers advancements in target databases and reverse docking tools.

Conclusions:

  • Key challenges remain, including target dataset construction, computational efficiency, receptor flexibility, and score normalization.
  • Resolving these issues is crucial for establishing reverse docking as a robust tool in drug discovery.